{
    "2018-09-15": [
        [
            {
                "time": "2023-10-12",
                "original_text": "Pfizer Reports Positive Phase 2 Data Of JAK Inhibitors In Alopecia Areata",
                "features": {
                    "keywords": [
                        "Pfizer",
                        "Positive Phase 2 Data",
                        "JAK Inhibitors",
                        "Alopecia Areata"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals",
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2023-10-12",
                "original_text": "Pfizer Presents Positive Phase 2 Data in Alopecia Areata During Late-Breaker Session at the 27th European Academy of Dermatology and Venereology (EADV) Congress",
                "features": {
                    "keywords": [
                        "Pfizer",
                        "Positive Phase 2 Data",
                        "Alopecia Areata",
                        "EADV Congress"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals",
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            }
        ]
    ]
}